Quality Control
We are actively taking measures to improve product quality levels.


Why Hamamatsu?


Our company

( )

Select your region and country.

To further accelerate R&D work for novel coronavirus (COVID-19) test reagents, Hamamatsu Photonics has developed a new fluorescence immunochromato reader with both high sensitivity and high reproducibility. Customer sales will begin on October 1st, 2020. This immunochromato reader will also be available as an OEM product for infectious disease diagnosis applications.


Immunochromato Reader C10066-60

Immunochromato Reader C10066-60

Here at Hamamatsu Photonics we have developed a new “Immunochromato Reader C10066-60” that gives precise readouts of fluorescence in immunochromatographic reagents. Its measurement sensitivity has been boosted more than 10 times higher than currently available products by applying our own advanced signal processing technology and optical design technology.

This new immunochromato reader (lateral flow reader) does high-sensitivity detection of reagent reactions occurring with antigens such as viruses and hormones or antibodies reacting with viruses, etc. It is a promising tool for streamlining R&D work on immunochromatographic reagents including those for novel coronavirus (COVID-19). We start accepting product orders from domestic and overseas reagent manufacturers on October 1st (Thu), 2020. We will also be supplying this immunochromato reader as a commercially available OEM (original equipment manufacturer) product that matches the reagents produced by each manufacturer.